3.50 USD
↗ 0.03 (0.72%)LIVE (AS OF 03:19 PM EDT)
Neuphoria Therapeutics Inc. Common Stock
NEUPNASDAQ • USD
Market: OPEN
Neuphoria Therapeutics Inc. Common Stock (NEUP) trades at $3.50 per share. Technical indicators currently signal "Strong Sell". Key drivers include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 2, 2026.
Open?$3.45
High?$3.53
Low?$3.42
Prev. Close?$3.47
Volume?11.4K
Avg. Volume?N/A
VWAP?$3.47
Bid / Ask
Bid?$2.94 × 100
Ask?$4.06 × 100
Spread?$1.12
Midpoint?$3.50
Valuation & Ratios
Market Cap?18.8M
Shares Out?5.4M
Float?4.7M
Float %?86.6%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company focused on therapies for serious central nervous system disorders. Its lead product candidate, BNC210, is an oral, proprietary, selective negative allosteric modulator of the alpha7 nicotinic acetylcholine receptor. The company has discontinued development of BNC210 for social anxiety disorder, while its BNC210 program for post-traumatic stress disorder is currently paused and no active clinical trial is underway. The company operates through a single operating and reporting segment focused on the discovery and development of allosteric ion-channel modulators for serious CNS disorders with high unmet medical need.
Employees
1
Market Cap
18.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-12-16
Address
100 SUMMIT DR
BURLINGTON, MA 01803
Phone: 781-439-5551
BURLINGTON, MA 01803
Phone: 781-439-5551
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.53%Low
Short Interest?24.7K
Days to Cover?1.2
Free Float4.7M
Avg Daily Volume20.2K
Settlement Date2026-09-15